- Home
- / Hantech Bio-Technology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hantech Bio-Technology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
NT$778.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 22, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 240.3M | 302.5M | 625.1M | 748.4M | 778.5M |
| Cost of goods sold | 120.6M | 156.6M | 323.3M | 410.6M | 451.5M |
| Gross profit | 120.3M | 146.1M | 302.3M | 338.8M | 327.9M |
| Gross profit margin, % | 50.1% | 48.3% | 48.4% | 45.3% | 42.1% |
| Operating expense total | 62.4M | 69.2M | 95.7M | 108.3M | 115.3M |
| Depreciation and amortization | 18.7M | 19.3M | 20.9M | 32.1M | 38.2M |
| EBITDA | 57.9M | 76.9M | 206.6M | 230.5M | 212.5M |
| EBITDA margin, % | 24.1% | 25.4% | 33.0% | 30.8% | 27.3% |
| EBIT | 39.1M | 57.0M | 185.5M | 198.1M | 173.0M |
| EBIT margin, % | 16.3% | 18.8% | 29.7% | 26.5% | 22.2% |
| Interest income | 46.0K | 267.0K | 654.0K | 1.4M | 3.3M |
| Interest expense | 1.5M | 1.5M | 2.1M | 5.4M | 3.0M |
| Pre tax profit | 38.4M | 57.7M | 184.6M | 194.6M | 173.0M |
| Income tax expense | 7.3M | 11.9M | 37.0M | 39.2M | 33.9M |
| Net Income | 31.1M | 45.9M | 147.5M | 155.4M | 139.1M |